On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Thanks to AI, data science tasks that once demanded specialized skills can now be performed faster, more accurately and at a ...

Gevo reported a $3.7 million loss from operations for the three months ended September 30, 2025, and positive Adjusted EBITDA 1 of approximately $6.7 million for the three months ended September 30, ...

H1-B visa reform is needed now. In the global race for chips and AI, the U.S. cannot continue treating this most important H1-B talent entry point like a lottery ticket.

Mark R. Ludwikowski and Laura M. Quesada of Clark Hill PLC examine how new tariffs on trucks signal the evolution of Section 232 from a national security safeguard into a broader instrument of U.S.

Ezra Klein and Aaron Retica discuss whether affordability is the Democrats’ winning message, Trump’s politics of cruelty and ...

Three research scientist entrepreneurs with roots in university labs and life sciences startup companies have announced ...

By AMINU JAHUN The realisation that a human being divested of basic rights could hardly effectively function in society led to the embedment of grund norms with grandiloquent terms and concepts, ...

Q4 2025 Earnings Call November 10, 2025 9:00 AM ESTCompany ParticipantsJon KatholDonnie King - President, CEO & ...

According to Towards FnB, the global edible offal market size is calculated at USD 45 billion in 2025 and is anticipated to ...

INLIGHT is currently ongoing at multiple trial sites, including in the US following clearance of an Investigational New Drug (IND) application. Wave has expanded Cohort 2, Cohort 3, and Cohort 4 (600 ...

Repligen Corporation ( RGEN) UBS Global Healthcare Conference 2025 November 10, 2025 11:00 AM EST All right. With that, we're ready to kick things off. Next up, we have Repligen. Representing the ...